Warfarin vs. Aspirin in Reduced Cardiac Ejection Fraction
Warfarin vs. Aspirin in Reduced Cardiac Ejection Fraction
The purpose of this study is to determine whether warfarin (INR) or aspirin (325 mg/day) is superior for preventing all cause mortality and stroke combined in patients with ejection fraction (EF) < 30% when balanced against any risk of intra-cerebral hemorrhage.
PATIENTS WITH A LOW EJECTION FRACTION WITH HEART FAILURE
YES
DR. SUSAN GRAHAM Sub Investigator: Virginia Hart, RN
Name: MARY BONORA
Phone: 716.859.4641
Email: MBONORA@KALEIDAHEALTH.ORG